These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6953525)

  • 41. [Modern trends in the development of radioprotective formulations (a review of the literature)].
    Vladimirov VG; Zaĭtseva TG
    Farmakol Toksikol; 1980; 43(2):244-9. PubMed ID: 7002603
    [No Abstract]   [Full Text] [Related]  

  • 42. The metabolic effects of cystamine and mexamine in dogs.
    Stoklasová A; Púlpánová J; Kovárová H
    Radiobiol Radiother (Berl); 1979 Oct; 20(5):652-6. PubMed ID: 297246
    [No Abstract]   [Full Text] [Related]  

  • 43. [Peculiarities of the accumulation of neutral red in the organs of the mouse at various intervals after the administration of radiation-protective agents].
    Zherebchenko PG; Zaĭtseva TG
    Radiobiologiia; 1967; 7(1):105-10. PubMed ID: 4305927
    [No Abstract]   [Full Text] [Related]  

  • 44. The influence of simultaneously administered mexamine on the distribution of cystamine-35S.
    Stoklasová A; Krízala J; Chmelar V
    Experientia; 1978 Jul; 34(7):870-1. PubMed ID: 276473
    [No Abstract]   [Full Text] [Related]  

  • 45. [Intertissue metabolism of serotonin after the administration of radioprotectors and its possible significance in radiation resistance].
    Kulinskiĭ VI; Cherkasova TI
    Radiobiologiia; 1974; 14(5):673-6. PubMed ID: 4431910
    [No Abstract]   [Full Text] [Related]  

  • 46. [Study of the radioprotective effects of optical isomers of S-(2-aminopentyl-isothiourea in experiments on mammals and in cells in vitro].
    Graevskiĭ EIa; Ianushevskaia MI; Mandrugin AA; Nekrasova IV; Bueverova EI
    Radiobiologiia; 1980; 20(5):752-5. PubMed ID: 6777823
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of the minimal dose of 5-methoxytryptamine affecting the accumulation of cystamine in tissues and its excretion with urine].
    Mordukhovich VV; Titov AV
    Radiobiologiia; 1970; 10(5):756-8. PubMed ID: 5486359
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of biogenic amines and ultraviolet radiation on the content of sulfhydryl groups in mouse liver, spleen and oxyhemoglobin].
    Kovaleva TA; Artiukhonov VG
    Radiobiologiia; 1983; 23(1):84-7. PubMed ID: 6828668
    [No Abstract]   [Full Text] [Related]  

  • 49. [Specificity of cystamine distribution in the organism of mice, rats and dogs].
    Titov AV; Golubentsov DA
    Farmakol Toksikol; 1971; 34(5):594-7. PubMed ID: 5151262
    [No Abstract]   [Full Text] [Related]  

  • 50. [Role of mixed-disulfide bonds in the radioprotective action of beta-mercaptoethylamine (MEA)].
    Filippovich IV; Zhulanova ZI; Kolina VB; Mikhaĭlova LP; Sheremet'evskaia TM
    Dokl Akad Nauk SSSR; 1972 Jun; 204(4):1006-9. PubMed ID: 5042377
    [No Abstract]   [Full Text] [Related]  

  • 51. Increase of radioprotective potency of 5-methoxytryptamine by means of calcium.
    Pospisil M; Netíková J
    Radiobiol Radiother (Berl); 1974; 15(4):521-4. PubMed ID: 4531650
    [No Abstract]   [Full Text] [Related]  

  • 52. Histopathological study of local changes after intramuscular administration of cysteamine or its combination with mexamine in rats.
    Resl M; Kuna P
    Radiobiol Radiother (Berl); 1984; 25(4):571-8. PubMed ID: 6594720
    [No Abstract]   [Full Text] [Related]  

  • 53. Protection of hemopoietic tissue in whole body gamma irradiated mice by cystamine given intramuscularly.
    Kuna P
    Radiobiol Radiother (Berl); 1981; 22(3):315-7. PubMed ID: 7302190
    [No Abstract]   [Full Text] [Related]  

  • 54. Distribution and behavior of isoselenouronium salts in the body. V. Acute toxicity and metabolic fate of selenium derivatives.
    Kozák I; Kronrád L; Dienstbier Z
    Strahlentherapie; 1976 Jan; 151(1):78-83. PubMed ID: 1258078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the protective effect of radioprotective substances by means of long-term changes in oxygen consumption.
    Misustová J; Hosek B; Kautská J
    Strahlentherapie; 1980 Nov; 156(11):790-4. PubMed ID: 6933726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of the radioprotectors, 2-mercaptoethylamine and 5-methoxytryptamine on the activity of reparative enzymes].
    Beliakova NV; Kravetskaia TP; Krutiakov VM
    Radiobiologiia; 1981; 21(2):198-203. PubMed ID: 6264539
    [No Abstract]   [Full Text] [Related]  

  • 57. [Distribution of cystaphos in animals with tumors].
    Aĭrapetian GM; Anorova GA; Kublik LN; Otarova GK; Pekarskiĭ MI; Stanko VN; Eĭdus LKh; Iarmonenko SP
    Med Radiol (Mosk); 1967 Mar; 12(3):58-65. PubMed ID: 5620463
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of 5-methoxytryptamine on cystamine distribution in an organism].
    Titov AV; Mordukhovich VV
    Radiobiologiia; 1969; 9(4):574-8. PubMed ID: 5375440
    [No Abstract]   [Full Text] [Related]  

  • 59. Protection against x-irradiation by sulphdryl compounds. I. Studies on the cellular uptake under various conditions of incubation.
    Zwenk H; Vergroesen AJ; Vos O
    Int J Radiat Biol Relat Stud Phys Chem Med; 1967; 13(1):69-76. PubMed ID: 5300418
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effect of beta-mercaptopropylamine on the amino nitrogen level and the depot of free amino acids in the spleen and liver of rats].
    Belavina AP; Blokhina VD; Romantsev EF
    Farmakol Toksikol; 1967; 30(1):92-4. PubMed ID: 5594368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.